Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sherman

Showing results (561-570 of 580) with videos related to

Pageof 58
Sort By:
Tuberculosis (Edinburgh, Scotland)|April 11, 2015
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screeningKaustuv Nayak, Lichen Jing, Ronnie M Russell, et al.
Diagnostic Microbiology and Infectious Disease|November 6, 2023
Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine developmentMing Chang, Sambasivan Venkatasubramanian, Holly Barrett, et al.
Mbio|April 5, 2023
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in CaseumJansy P Sarathy, Min Xie, Richard M Jones, et al.
Nature Communications|January 13, 2015
The DNA-binding network of Mycobacterium tuberculosisKyle J Minch, Tige R Rustad, Eliza J R Peterson, et al.
American Journal of Surgery|November 15, 2017
Assessing the 16 hour intern shift limit: Results of a multi-center, mixed-methods study of residents and faculty in general surgeryJames E Coverdill, Adnan Alseidi, David C Borgstrom, et al.
The Journal of Clinical Investigation|December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionPhilana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2025
Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trialLauren T Ptomey, Joseph E Donnelly, Jeffery Burns, et al.
Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.
American Journal of Surgery|November 16, 2017
The promise and problems of non-physician practitioners in general surgery education: Results of a multi-center, mixed-methods study of facultyJames E Coverdill, Jeff Scott Shelton, Adnan Alseidi, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Pageof 58

Showing results (561-570 of 580) with videos related to

Sort By:
Pageof 58
Tuberculosis (Edinburgh, Scotland)|April 11, 2015
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screeningKaustuv Nayak, Lichen Jing, Ronnie M Russell, et al.
Diagnostic Microbiology and Infectious Disease|November 6, 2023
Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine developmentMing Chang, Sambasivan Venkatasubramanian, Holly Barrett, et al.
Mbio|April 5, 2023
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in CaseumJansy P Sarathy, Min Xie, Richard M Jones, et al.
Nature Communications|January 13, 2015
The DNA-binding network of Mycobacterium tuberculosisKyle J Minch, Tige R Rustad, Eliza J R Peterson, et al.
American Journal of Surgery|November 15, 2017
Assessing the 16 hour intern shift limit: Results of a multi-center, mixed-methods study of residents and faculty in general surgeryJames E Coverdill, Adnan Alseidi, David C Borgstrom, et al.
The Journal of Clinical Investigation|December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionPhilana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2025
Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trialLauren T Ptomey, Joseph E Donnelly, Jeffery Burns, et al.
Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.
American Journal of Surgery|November 16, 2017
The promise and problems of non-physician practitioners in general surgery education: Results of a multi-center, mixed-methods study of facultyJames E Coverdill, Jeff Scott Shelton, Adnan Alseidi, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Pageof 58